1. Effect of stereotactic body radiotherapy dose escalation plus pembrolizumab and trametinib versus stereotactic body radiotherapy dose escalation plus gemcitabine for locally recurrent pancreatic cancer after surgical resection on survival outcomes: a secondary analysis of an open-label, randomised, controlled, phase 2 trial. (January 2023) Authors: Zhu, Xiaofei; Liu, Wenyu; Cao, Yangsen; Ju, Xiaoping; Zhao, Xianzhi; Jiang, Lingong; Ye, Yusheng; Zhang, Huojun Journal: EClinicalMedicine Issue: Volume 55(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study. (December 2020) Authors: Zhu, Xiaofei; Cao, Yangsen; Su, Tingshi; Zhu, Xixu; Ju, Xiaoping; Zhao, Xianzhi; Jiang, Lingong; Ye, Yusheng; Cao, Fei; Qing, Shuiwang; Zhang, Huojun Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Personalized designs of adjuvant radiotherapy for pancreatic cancer based on molecular profiles. Issue 1 (7th November 2020) Authors: Zhu, Xiaofei; Cao, Yangsen; Ju, Xiaoping; Zhao, Xianzhi; Jiang, Lingong; Ye, Yusheng; Shen, Yuxin; Cao, Fei; Qing, Shuiwang; Zhang, Huojun Journal: Cancer science Issue: Volume 112:Issue 1(2021) Page Start: 287 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Prediction of overall survival after re-irradiation with stereotactic body radiation therapy for pancreatic cancer with a novel prognostic model (the SCAD score). Issue 2 (November 2018) Authors: Zhu, Xiaofei; Li, Fuqi; Ju, Xiaoping; Shen, Yuxin; Cao, Yangsen; Cao, Fei; Fang, Fang; Qing, Shuiwang; Jia, Zhen; Zhang, Huojun Journal: Radiotherapy and oncology Issue: Volume 129:Issue 2(2018) Page Start: 313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Prognostic role of stereotactic body radiation therapy for elderly patients with advanced and medically inoperable pancreatic cancer. (23rd August 2017) Authors: Zhu, Xiaofei; Li, Fuqi; Ju, Xiaoping; Cao, Fei; Cao, Yangsen; Fang, Fang; Qing, Shuiwang; Shen, Yuxin; Jia, Zhen; Zhang, Huojun Journal: Cancer medicine Issue: Volume 6:Number 10(2017:Oct.) Page Start: 2263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Prospective analysis of different combined regimens of stereotactic body radiation therapy and chemotherapy for locally advanced pancreatic cancer. (17th May 2018) Authors: Zhu, Xiaofei; Shi, Dongchen; Li, Fuqi; Ju, Xiaoping; Cao, Yangsen; Shen, Yuxin; Cao, Fei; Qing, Shuiwang; Fang, Fang; Jia, Zhen; Zhang, Huojun Journal: Cancer medicine Issue: Volume 7:Number 7(2018:Jul.) Page Start: 2913 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. RETRACTION: Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial. Issue 8 (August 2021) Authors: Zhu, Xiaofei; Cao, Yangsen; Liu, Wenyu; Ju, Xiaoping; Zhao, Xianzhi; Jiang, Lingong; Ye, Yusheng; Jin, Gang; Zhang, Huojun Journal: Lancet oncology Issue: Volume 22:Issue 8(2021) Page Start: 1093 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial. Issue 12 (1st December 2016) Authors: Zhu, Xiaofei; Ju, Xiaoping; Cao, Fei; Fang, Fang; Qing, Shuiwang; Shen, Yuxin; Jia, Zhen; Cao, Yangsen; Zhang, Huojun Journal: BMJ open Issue: Volume 6:Issue 12(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Stereotactic body radiation therapy with sequential S-1 for patients with locally advanced pancreatic cancer and poor performance status: An open-label, single-arm, phase 2 trial. (September 2021) Authors: Zhu, Xiaofei; Cao, Yangsen; Lu, Mingzhi; Zhao, Xianzhi; Jiang, Lingong; Ye, Yusheng; Ju, Xiaoping; Zhang, Huojun Journal: Radiotherapy and oncology Issue: Volume 162(2021) Page Start: 178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial. Issue 3 (March 2022) Authors: Zhu, Xiaofei; Cao, Yangsen; Liu, Wenyu; Ju, Xiaoping; Zhao, Xianzhi; Jiang, Lingong; Ye, Yusheng; Jin, Gang; Zhang, Huojun Journal: Lancet oncology Issue: Volume 23:Issue 3(2022) Page Start: e105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗